Drugs.com - Monthly Update January 2026 скачать в хорошем качестве

Drugs.com - Monthly Update January 2026

In our latest episode, we cover the latest approval of Darzalex Faspro for multiple myeloma, age-related near vision loss, and a rare genetic disorder affecting children. We also discuss an extension to the use of Nexplanon, a long-acting birth control, and a simpler transition for those moving from injected to inhaled insulin. Darzalex Faspro (daratumumab and hyaluronidase-fihj) a new approval for use in combination with standard treatments for adults with newly diagnosed multiple myeloma. https://www.drugs.com/darzalex.html Yuvezzi (carbachol and brimonidine tartrate), a novel combination eye drop for presbyopia. https://www.drugs.com/yuvezzi.html Zycubo (copper histidinate), the first treatment for Menkes disease in children. https://www.drugs.com/zycubo.html Nexplanon (etonogestrel), a birth control implant with an extension of use for up to five years. https://www.drugs.com/nexplanon.html Afrezza (insulin human), an inhaled insulin, with updated dosing guidance. https://www.drugs.com/afrezza.html Chapters 00:00 - Intro 00:21 - Overview 00:47 - Darzalex 02:13 - Yuvezzi 03:06 - Zycubo 03:50 - Nexplanon 04:35 - Afrezza 05:09 - Outro Follow Drugs.com: Twtter/X -   / drugscom   Facebook -   / drugscom   Signup to our newsletters - https://www.drugs.com/newsletters/ Download the app - https://www.drugs.com/apps/